David J. Gocke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Latest Publications
- Open Access
- 15 February 2006
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (4) , 575-576
Safety of Aseptically Processed Allograft Tissue
Sir—Crawford et al. [1] reported postoperative infection in patients who underwent musculoskeletal allograft implantation that, as they concluded, was associated with aseptically processed grafts but not with “sterile” grafts (as if aseptically processed tissue is not sterile). However, they also found that these surgical site infections were strongly associated with the use of a supplementary staple and with tibial fixation, but not with femoral fixation. How would Crawford and colleagues propose to explain this curious finding? Could only one end of the graft be contaminated? Also, they report that the median time to positive culture results was 55 days, which seems to be a very long interval for infection caused by a contaminated allograft. These observations raise serious questions, and before rushing to the easy conclusion that aseptically processed tissue is unsafe, a number of other factors need to be addressed.
- 15 February 2006
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (4) , 575-576
Open AccessSafety of Aseptically Processed Allograft Tissue
Sir—Crawford et al. [1] reported postoperative infection in patients who underwent musculoskeletal allograft implantation that, as they concluded, was associated with aseptically processed grafts but not with “sterile” grafts (as if aseptically processed tissue is not sterile). However, they also found that these surgical site infections were strongly associated with the use of a supplementary staple and with tibial fixation, but not with femoral fixation. How would Crawford and colleagues propose to explain this curious finding? Could only one end of the graft be contaminated? Also, they report that the median time to positive culture results was 55 days, which seems to be a very long interval for infection caused by a contaminated allograft. These observations raise serious questions, and before rushing to the easy conclusion that aseptically processed tissue is unsafe, a number of other factors need to be addressed.
- 1 June 2005
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. &NA; (435) , 17-21
Tissue Donor Selection and Safety
Authors of recent reports in the medical literature indicate that allograft-associated infection primarily is attributable to violations of proper tissue processing procedures, and illustrate the need for effective quality assurance systems to avoid transplantation of potentially infectious tissue. I describe the experience of the members of the Musculoskeletal Transplant Foundation with the selection, the processing, and the safety of bone and tissue donors for allograft implantation. In 2002, the Musculoskeletal Transplant Foundation screened 10,497 potential donors, but only 4431 (42%) met stringent criteria for recovery. After recovery, another 10% of the donors were rejected, usually because of positive infectious disease tests (45%) or an autopsy finding (31%) that rendered the tissues unsuitable for transplantation. Procedures used by the Musculoskeletal Transplant Foundation for ensuring safety of the tissue and for investigating reports of putative infection are described. The Musculoskeletal Transplant Foundation has had no confirmed cases of allograft-associated infection in over 2 million units transplanted during the past 15 years.
- 1 June 2005
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. &NA; (435) , 17-21
Tissue Donor Selection and Safety
Authors of recent reports in the medical literature indicate that allograft-associated infection primarily is attributable to violations of proper tissue processing procedures, and illustrate the need for effective quality assurance systems to avoid transplantation of potentially infectious tissue. I describe the experience of the members of the Musculoskeletal Transplant Foundation with the selection, the processing, and the safety of bone and tissue donors for allograft implantation. In 2002, the Musculoskeletal Transplant Foundation screened 10,497 potential donors, but only 4431 (42%) met stringent criteria for recovery. After recovery, another 10% of the donors were rejected, usually because of positive infectious disease tests (45%) or an autopsy finding (31%) that rendered the tissues unsuitable for transplantation. Procedures used by the Musculoskeletal Transplant Foundation for ensuring safety of the tissue and for investigating reports of putative infection are described. The Musculoskeletal Transplant Foundation has had no confirmed cases of allograft-associated infection in over 2 million units transplanted during the past 15 years.